Olive oil

DB09567ApprovedInvestigationalLipid Emulsion

Oil extracted from olives . Consists primarily of the glycerides of the fatty acids linoleic, oleic and palmitic. Used as a source of fatty acids in total parenteral nutrition and...

Mechanism: Fatty acids act as a substrate in energy production through beta-oxidation as well as important components of cell membrane structures and prescursors for bioactive molecules like prostaglandins.
Curator reviewed
Primary indication: In a clinical context, olive oil is used as a source of calories and fatty acids in patients requiring parenteral nutrition.Curator reviewed · 3 structured indications
First approval: Canada, 2010 · United States, 2016
Brand names: Clinoleic
Clinolipid
Olimel
Periolimel

Resolves to

Compound

UNII6UYK2W1W1ECAS8001-25-0

Clinical / RWD

RxNorm1309250

What you can answer from here — as of September 01, 2026

87Drug interactionsStructured to mechanism, not free text

82Clinical trialsPhase, status and sponsor resolved per trial

3Structured indicationsCondition, population, route and combination as fields, not prose

145Marketed productsAcross 9 countries and 19 labellers

8+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Olive oil, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account